Personal tools

Coexpression cluster:C1474: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|gostat_on_coexpression_clusters=GO:0004864!protein phosphatase inhibitor activity!0.0164759143109795!65979$GO:0019212!phosphatase inhibitor activity!0.0164759143109795!65979$GO:0019888!protein phosphatase regulator activity!0.0192869987391987!65979$GO:0019208!phosphatase regulator activity!0.0192869987391987!65979
|gostat_on_coexpression_clusters=GO:0004864!protein phosphatase inhibitor activity!0.0164759143109795!65979$GO:0019212!phosphatase inhibitor activity!0.0164759143109795!65979$GO:0019888!protein phosphatase regulator activity!0.0192869987391987!65979$GO:0019208!phosphatase regulator activity!0.0192869987391987!65979
|id=C1474
|id=C1474
|ontology_enrichment_celltype=CL:0002320!3.36e-18!365;CL:0000048!3.86e-18!430;CL:0000134!2.23e-17!358;CL:0000723!3.20e-16!436;CL:0000034!1.84e-15!444;CL:0000219!6.90e-14!390;CL:0000763!1.43e-12!112;CL:0000049!1.43e-12!112;CL:0000557!3.58e-12!71;CL:0002057!1.59e-11!42;CL:0002371!8.02e-11!591;CL:0000860!2.66e-10!45;CL:0000766!3.18e-10!76;CL:0000839!9.55e-10!70;CL:0000144!1.82e-09!625;CL:0002009!2.62e-09!65;CL:0000012!3.53e-09!682;CL:0002194!2.11e-08!63;CL:0000576!2.11e-08!63;CL:0000040!2.11e-08!63;CL:0000559!2.11e-08!63;CL:0000063!2.78e-08!578;CL:0000548!4.21e-08!679;CL:0000004!4.21e-08!679;CL:0000255!4.21e-08!679;CL:0000057!1.31e-07!75;CL:0002620!5.98e-07!23
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002384!8.38e-18!375;UBERON:0004765!8.60e-15!101;UBERON:0001434!8.60e-15!101;UBERON:0001474!2.94e-14!86;UBERON:0002371!7.52e-14!80;UBERON:0002204!3.76e-13!167;UBERON:0002193!1.42e-11!112;UBERON:0002390!4.86e-11!102;UBERON:0003061!4.86e-11!102;UBERON:0002405!5.08e-09!115;UBERON:0000926!2.34e-07!448;UBERON:0004120!2.34e-07!448;UBERON:0006603!2.34e-07!448
}}
}}

Revision as of 14:12, 21 May 2012


Full id: C1474_Mast_CD34_immature_CD14_CD133_pleomorphic_granulocyte



Phase1 CAGE Peaks

Hg19::chr1:28764653..28764670,+p2@PHACTR4
Hg19::chr3:15839437..15839503,-p1@ANKRD28
Hg19::chr3:15839515..15839526,-p11@ANKRD28
Hg19::chr3:15839528..15839539,-p14@ANKRD28
Hg19::chr3:15839573..15839583,-p15@ANKRD28
Hg19::chr3:15839586..15839603,-p7@ANKRD28


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0004864protein phosphatase inhibitor activity0.0164759143109795
GO:0019212phosphatase inhibitor activity0.0164759143109795
GO:0019888protein phosphatase regulator activity0.0192869987391987
GO:0019208phosphatase regulator activity0.0192869987391987



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
connective tissue8.38e-18375
skeletal element8.60e-15101
skeletal system8.60e-15101
bone element2.94e-1486
bone marrow7.52e-1480
musculoskeletal system3.76e-13167
hemolymphoid system1.42e-11112
hematopoietic system4.86e-11102
blood island4.86e-11102
immune system5.08e-09115
mesoderm2.34e-07448
mesoderm-derived structure2.34e-07448
presumptive mesoderm2.34e-07448


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.